[HTML][HTML] ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

J Li, M Fredericks, M Cannell, K Wang… - The Journal of …, 2021 - Am Soc Clin Investig
Patients with neuromuscular disorders suffer from a lack of treatment options for skeletal
muscle weakness and disease comorbidities. Here, we introduce as a potential therapeutic …

ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders.

J Li, M Fredericks, M Cannell, K Wang… - The Journal of …, 2021 - europepmc.org
Patients with neuromuscular disorders suffer from a lack of treatment options for skeletal
muscle weakness and disease comorbidities. Here, we introduce as a potential therapeutic …

ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

J Li, M Fredericks, M Cannell… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Patients with neuromuscular disorders suffer from a lack of treatment options for skeletal
muscle weakness and disease comorbidities. Here, we introduce as a potential therapeutic …

[HTML][HTML] ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

J Li, M Fredericks, M Cannell, K Wang… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Patients with neuromuscular disorders suffer from a lack of treatment options for skeletal
muscle weakness and disease comorbidities. Here, we introduce as a potential therapeutic …

ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders.

J Li, M Fredericks, M Cannell, K Wang… - Journal of Clinical …, 2021 - go.gale.com
Patients with neuromuscular disorders suffer from a lack of treatment options for skeletal
muscle weakness and disease comorbidities. Here, we introduce as a potential therapeutic …

ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

J Li, M Fredericks, M Cannell, K Wang… - Journal of Clinical …, 2021 - search.proquest.com
Patients with neuromuscular disorders suffer from a lack of treatment options for skeletal
muscle weakness and disease comorbidities. Here, we introduce as a potential therapeutic …

[PDF][PDF] ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

J Li, M Fredericks, M Cannell, K Wang, D Sako… - 2021 - academia.edu
Neuromuscular disorders (NMDs) encompass a wide range of conditions with impaired
muscle function. Such disorders include disuse atrophy, in which unloading and inactivity …

ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

J Li, M Fredericks, M Cannell… - Journal of Clinical …, 2021 - scholar.barrowneuro.org
Patients with neuromuscular disorders suffer from a lack of treatment options for skeletal
muscle weakness and disease comorbidities. Here, we introduce as a potential therapeutic …

[引用][C] ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

J Li, M Fredericks, M Cannell, K Wang, D Sako… - Journal of Clinical …, 2021 - cir.nii.ac.jp
ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of
neuromuscular disorders | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

[PDF][PDF] ActRIIB: ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

J Li, M Fredericks, M Cannell, K Wang, D Sako… - 2021 - academia.edu
Neuromuscular disorders (NMDs) encompass a wide range of conditions with impaired
muscle function. Such disorders include disuse atrophy, in which unloading and inactivity …